Methods to induce targeted protein degradation through bifunctional molecules
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
56128661&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
56128661&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
IRAK degraders and uses thereof
N Mainolfi, N Ji, AF Kluge, MM Weiss… - US Patent 10,874,743, 2020 - Google Patents
2019-01-10 Assigned to KYMERA THERAPEUTICS, INC. reassignment KYMERA
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
Regulated biocircuit systems
P Barrett, MN Gladstone, TA Kassum, V Suri… - US Patent …, 2022 - Google Patents
US11446398B2 - Regulated biocircuit systems - Google Patents US11446398B2 -
Regulated biocircuit systems - Google Patents Regulated biocircuit systems Download PDF …
Regulated biocircuit systems - Google Patents Regulated biocircuit systems Download PDF …
Tricyclic CRBN ligands and uses thereof
N Ji, AF Kluge, MM Weiss, Y Zhang - US Patent 11,292,792, 2022 - Google Patents
US11292792B2 - Tricyclic CRBN ligands and uses thereof - Google Patents
US11292792B2 - Tricyclic CRBN ligands and uses thereof - Google Patents Tricyclic CRBN …
US11292792B2 - Tricyclic CRBN ligands and uses thereof - Google Patents Tricyclic CRBN …
Targeted protein degradation using a mutant E3 ubiquitin ligase
J Bradner, M Ishoey, D Buckley, J Paulk… - US Patent …, 2019 - Google Patents
2018-08-22 Assigned to DANA-FARBER CANCER INSTITUTE, INC. reassignment DANA-
FARBER CANCER INSTITUTE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
FARBER CANCER INSTITUTE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
Protein degraders and uses thereof
N Mainolfi, N Ji, AF Kluge - US Patent 11,485,743, 2022 - Google Patents
NCOFGNKEWNANKP-UHFFFAOYSA-N CC (C) C (= O) CN (C) C (C) C. CC (C) C (= O) CN
(C) C (C) C. CC (C) CCOC (C) C. CC (C) CCOC (C) C. CC (C) COCC (C) C Chemical …
(C) C (C) C. CC (C) CCOC (C) C. CC (C) CCOC (C) C. CC (C) COCC (C) C Chemical …
CRBN ligands and uses thereof
N Mainolfi, N Ji, AF Kluge - US Patent 11,512,080, 2022 - Google Patents
US11512080B2 - CRBN ligands and uses thereof - Google Patents US11512080B2 - CRBN
ligands and uses thereof - Google Patents CRBN ligands and uses thereof Download PDF Info …
ligands and uses thereof - Google Patents CRBN ligands and uses thereof Download PDF Info …
IRAK degraders and uses thereof
N Mainolfi, N Ji, AF Kluge, MM Weiss, Y Zhang… - US Patent …, 2022 - Google Patents
2019-12-20 Assigned to KYMERA THERAPEUTICS, INC. reassignment KYMERA
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
IRAK degraders and uses thereof
N Mainolfi, N Ji, AF Kluge, MM Weiss, Y Zhang… - US Patent …, 2021 - Google Patents
2020-09-22 Assigned to KYMERA THERAPEUTICS, INC. reassignment KYMERA
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
IRAK degraders and uses thereof
MM Weiss - US Patent 11,779,578, 2023 - Google Patents
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …
carriers or inert additives; Targeting or modifying agents chemically bound to the active …